Suchergebnisse - "Drug Therapy, Combination"

PubPharm (710)

21

Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance

enthalten in: Journal for immunotherapy of cancer | 2023

von James, J. | Taylor, B. | Axelrod, M. | +11

22

The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus : A Randomized, Multicenter, Open, Parallel, Phase 4 Study

enthalten in: Diabetes & metabolism journal | 2023

von Moon, J. | Park, I. | Kim, S. | +8

23

MCT4 blockade increases the efficacy of immune checkpoint blockade

enthalten in: Journal for immunotherapy of cancer | 2023

von Babl, N. | Decking, S. | Voll, F. | +23

24

Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer

enthalten in: Journal for immunotherapy of cancer | 2023

von Akce, M. | Farran, B. | Switchenko, J. | +11

25

PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity

enthalten in: Journal for immunotherapy of cancer | 2023

von Koller, P. | Baran, N. | Harutyunyan, K. | +12

26

AdvanTIG-105 : a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2023

von Frentzas, S. | Kao, S. | Gao, R. | +6

27

SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models

enthalten in: Journal for immunotherapy of cancer | 2023

von Gray, E. | Ulrich, M. | Epp, A. | +22

28

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma : a single-arm, phase II trial

enthalten in: Journal for immunotherapy of cancer | 2023

von Zhang, W. | Tong, S. | Hu, B. | +22

29

Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer : an integrated clinical and radiomics approach

enthalten in: Journal for immunotherapy of cancer | 2023

von Zhao, J. | He, Y. | Yang, X. | +12

30

ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models

enthalten in: Journal for immunotherapy of cancer | 2023

von Jin, W. | Zangl, L. | Hyun, M. | +4